BiotechTube
Home/AAVogen/Buel "Dan" Rodgers, PhD
B"

Buel "Dan" Rodgers, PhD

Founder & CEO

AAVogen

Therapeutic Areas

Muscle Wasting DiseasesNeuromuscular DiseasesCardiovascular Disease

AAVogen Pipeline

DrugIndicationPhase
AVGN7Inclusion Body Myositis (IBM)Pre-clinical
AVGN7 + AVGNDDuchenne Muscular Dystrophy (DMD)Pre-clinical

Leadership Team at AAVogen

AM
Alexandra McPherron, PhD
Chief Scientific Officer (CSO)
JB
Jade Brown, MBA
Business Development Director
CN
Chris Novashinski
Regulatory Affairs Director, Co-Founder & COO (RareMoon)
JR
Joseph Rininger, PhD
CMC Director
GC
Gary Carswell, CPA
CFO (contracted)
View full AAVogen profile